Matzim La recalls
Matzim La products have been recalled 2 times, most recently on 10 Aug 2022. The recalling company is usually Teva Pharmaceuticals U. The most common reason is potency & assay.
Total recalls2since 2019
Last 12 months0reported
Class I00% of total
Ongoing0latest 10 Aug 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 50%Class III 1 50%
Why matzim la is recalled
Companies
Product types
By year
All matzim la recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 180 mg recalledMatzim La | Teva Pharmaceuticals USA | Potency & Assay | Nationwide |
| Drug | CLASS III | Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg recalledMatzim La | Teva Pharmaceuticals U | Processing Deviation | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.